Calendar

An AMCP LINK Webinar.

As 2026 begins, prior authorization and utilization management remain at the center of payer strategy and regulatory scrutiny. This Prior Authorization and Utilization Management LINKs kickoff webinar will explore the current policy landscape - what's changing, what's proposed, and what it means for your daily work. This will be a discussion-forward session focused on:

• The State of Play
• Disconnects and Realities
• Operational Impacts

Join us to share insights, surface pain points, and help shape AMCP's advocacy and practice agenda for 2026. Your voice will guide where policy meets practice.

A Pre-Approval Information Exchange (PIE) Webinar, presented by Novo Nordisk Inc.

Denecimig is a novel FVIIIa mimetic agent currently under investigation for the treatment of hemophilia A (congenital FVIII deficiency) with or without FVIII inhibitors. Denecimig has not been approved for any indication by any regulatory authority. This webinar will offer healthcare decision-makers an overview of the burden of disease in patients with hemophilia A, a detailed introduction to denecimig, its delivery (dosing and administration), and a summary of its clinical trial program.

This webinar is only offered to payers, formulary committees, or other similar entities responsible for the selection of drugs for coverage or reimbursement. In order to join this webinar, you must be registered as a user of FormularyDecisions®.

This product is in the clinical evaluation stage and has not been approved for use by the FDA.

Rare diseases pose significant challenges for managed care, requiring innovative solutions and a deep understanding of patient needs. Join this virtual event spotlighting four rare diseases. Through discussion of emerging therapies, patient journeys, and managed care strategies, attendees will gain practical insights for improving access, supporting adherence, and advancing equitable care for those affected by rare diseases.

11am-12:15 pm
Rare Disease Spotlight: Disease Burden, Unmet Needs, and Amplifying the Patient Voice - Managed Care Insights into Hereditary Angioedema and Beta Thalassemia

2-3:15pm ET
Rare Disease Spotlight: Disease Burden, Unmet Needs, and Amplifying the Patient Voice - Managed Care Insights into Myasthenia Gravis and Phenylketonuria

A Science & Innovation Webinar, presented by Abbvie.

Alopecia Areata is more than a cosmetic hair loss concern. It is a chronic, autoimmune disease characterized by unpredictable, non-scarring hair loss that can affect the scalp, face, and body. While its most visible manifestation is hair loss, AA reflects underlying immune dysregulation that may extend beyond hair loss. If left untreated or poorly managed, AA can be associated with a range of comorbidities—including Systemic Lupus Erythematosus (SLE), vitiligo, and atopic dermatitis. The psychosocial toll of AA, which may include anxiety, depression, PTSD, stress, social stigma, and social withdrawal, compounds the disease burden and can adversely impact patient outcomes and quality of life.

A Science & Innovation Webinar, presented by Eisai.

Advances in Alzheimer's disease (AD) diagnostics are reshaping clinical practice, making early and precise detection possible. Explore the latest clinical insights related to blood-based biomarkers, which include their importance in AD and appropriate utilization for patient care.